阿司匹林和氯吡格雷抵抗：方法学挑战与机遇
Aspirin and clopidogrel resistance: methodological challenges and opportunities.
作者信息
Gasparyan Armen Yuri
机构信息
Clinical Research Unit, Russell's Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust, West Midlands, UK.
出版信息
Vasc Health Risk Manag. 2010 Mar 24;6:109-12. doi: 10.2147/vhrm.s9087.
Abstract
Antiplatelet drug resistance is one of the urgent issues in current cardiovascular medicine. Many platelet function tests have been used to define responsiveness of patients with cardiovascular disease to aspirin and clopidogrel. In most studies, cut-off values of platelet function tests for defining responsiveness to antiplatelets were chosen arbitrarily. Different tests provided wide-ranging figures of the prevalence of aspirin and clopidogrel resistance, suggesting poor correlation between currently available platelet function tests. Measurement of platelet size seems to be a promising approach for monitoring antiplatelet drug therapy. This commentary highlights some limitations of studies on aspirin and clopidogrel resistance in patients undergoing coronary interventions.
摘要
抗血小板药物抵抗是当前心血管医学中亟待解决的问题之一。许多血小板功能测试已被用于确定心血管疾病患者对阿司匹林和氯吡格雷的反应性。在大多数研究中，用于定义对抗血小板药物反应性的血小板功能测试的临界值是任意选择的。不同的测试给出了阿司匹林和氯吡格雷抵抗发生率的广泛数据，这表明目前可用的血小板功能测试之间相关性较差。血小板大小的测量似乎是监测抗血小板药物治疗的一种有前景的方法。本述评强调了在接受冠状动脉介入治疗的患者中关于阿司匹林和氯吡格雷抵抗研究的一些局限性。
相似文献
1
Aspirin and clopidogrel resistance: methodological challenges and opportunities.阿司匹林和氯吡格雷抵抗：方法学挑战与机遇
Vasc Health Risk Manag. 2010 Mar 24;6:109-12. doi: 10.2147/vhrm.s9087.
2
Clopidogrel and aspirin in cardiovascular medicine: responders or not--current best available evidence.心血管医学中的氯吡格雷与阿司匹林：是否为反应者——当前最佳可得证据
Cardiovasc Hematol Agents Med Chem. 2008 Oct;6(4):312-22. doi: 10.2174/187152508785909483.
3
Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy.血小板对阿司匹林和氯吡格雷治疗反应变异性的评估、机制及临床意义
Am J Cardiol. 2009 Jul 15;104(2):227-33. doi: 10.1016/j.amjcard.2009.03.022. Epub 2009 May 13.
4
Comparison of current platelet functional tests for the assessment of aspirin and clopidogrel response. A review of the literature.比较当前血小板功能检测在评估阿司匹林和氯吡格雷反应中的应用。文献综述。
Thromb Haemost. 2016 Sep 27;116(4):638-50. doi: 10.1160/TH15-11-0870. Epub 2016 Jul 21.
5
How I use laboratory monitoring of antiplatelet therapy.我如何使用实验室监测抗血小板治疗。
Blood. 2017 Aug 10;130(6):713-721. doi: 10.1182/blood-2017-03-742338. Epub 2017 Jun 9.
6
Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.经药物洗脱支架治疗的患者阿司匹林和氯吡格雷低反应性的影响：一项前瞻性、多中心注册研究的 2 年结果。
JACC Cardiovasc Interv. 2017 Aug 28;10(16):1607-1617. doi: 10.1016/j.jcin.2017.05.059. Epub 2017 Aug 2.
7
Platelet function and antiplatelet therapy in cardiovascular disease: implications of genetic polymorphisms.血小板功能和心血管疾病中的抗血小板治疗：遗传多态性的影响。
Curr Vasc Pharmacol. 2011 Jul 1;9(4):479-89. doi: 10.2174/157016111796197224.
8
Clinical use of clopidogrel.氯吡格雷的临床应用。
Curr Pharm Des. 2012;18(33):5224-39. doi: 10.2174/138161212803251853.
9
Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.氯吡格雷治疗对阿司匹林治疗的稳定型冠状动脉疾病患者应激诱导的血小板活化及心肌缺血的影响。
Thromb Haemost. 2007 Dec;98(6):1316-22. doi: 10.1160/th07-05-0323.
10
Aspirin and clopidogrel resistance.阿司匹林和氯吡格雷抵抗
Mayo Clin Proc. 2006 Apr;81(4):518-26. doi: 10.4065/81.4.518.
引用本文的文献
1
Safety of Oral P2Y12 Inhibitors in Interventional Neuroradiology: Current Status and Perspectives.经皮血管内介入神经放射学中口服 P2Y12 抑制剂的安全性：现状与展望。
AJNR Am J Neuroradiol. 2021 Dec;42(12):2119-2126. doi: 10.3174/ajnr.A7303. Epub 2021 Oct 21.
2
Small bowel ulcer bleeding due to suspected clopidogrel use in a patient with clopidogrel resistance: A case report.一名存在氯吡格雷抵抗的患者因疑似使用氯吡格雷导致小肠溃疡出血：一例报告。
World J Clin Cases. 2021 May 26;9(15):3689-3695. doi: 10.12998/wjcc.v9.i15.3689.
3
P2Y12 inhibitors for the neurointerventionalist.神经介入医师用 P2Y12 抑制剂
Interv Neuroradiol. 2022 Feb;28(1):92-103. doi: 10.1177/15910199211015042. Epub 2021 May 4.
4
Mean platelet volume/platelet count ratio as a predictor of stent thrombosis in patients with ST-segment-elevation myocardial infarction.血小板平均体积/血小板计数比值对 ST 段抬高型心肌梗死患者支架血栓形成的预测作用。
Ir J Med Sci. 2021 Aug;190(3):1095-1102. doi: 10.1007/s11845-021-02626-y. Epub 2021 Apr 24.
5
Independent predictors of acute kidney injury in patients with acute coronary syndrome after percutaneous coronary intervention.经皮冠状动脉介入治疗后急性冠状动脉综合征患者急性肾损伤的独立预测因子。
PLoS One. 2021 Mar 4;16(3):e0247304. doi: 10.1371/journal.pone.0247304. eCollection 2021.
6
Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy.监测氯吡格雷治疗的药代动力学、药效学和药物遗传学检测。
Pharmacol Res Perspect. 2020 Dec;8(6):e00686. doi: 10.1002/prp2.686.
7
Platelet Function Testing in Neurovascular Procedures: Tool or Gimmick?神经血管手术中的血小板功能检测：工具还是噱头？
Interv Neurol. 2020 Jan;8(2-6):123-134. doi: 10.1159/000496702. Epub 2019 Feb 28.
8
Aspirin and Clopidogrel Resistance in Indian Patients with Ischemic Stroke and its Associations with Gene Polymorphisms: A Pilot Study.印度缺血性中风患者的阿司匹林和氯吡格雷抵抗及其与基因多态性的关联：一项初步研究。
Ann Indian Acad Neurol. 2019 Apr-Jun;22(2):147-152. doi: 10.4103/aian.AIAN_4_18.
9
Point of Care Tests VerifyNow P2Y12 and INNOVANCE PFA P2Y Compared to Light Transmittance Aggregometry After Fibrinolysis.纤溶后即时检测VerifyNow P2Y12和INNOVANCE PFA P2Y与透光率聚集法的比较
Clin Appl Thromb Hemost. 2018 Oct;24(7):1109-1116. doi: 10.1177/1076029618772354. Epub 2018 May 2.
10
Does i-T744C P2Y12 Polymorphism Modulate Clopidogrel Response among Moroccan Acute Coronary Syndromes Patients?i-T744C P2Y12基因多态性是否会调节摩洛哥急性冠脉综合征患者对氯吡格雷的反应？
Genet Res Int. 2017;2017:9532471. doi: 10.1155/2017/9532471. Epub 2017 Feb 5.
本文引用的文献
1
Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting.冠状动脉支架置入患者中阿司匹林和氯吡格雷低反应性及无反应性
Vasc Health Risk Manag. 2009;5:965-72. doi: 10.2147/vhrm.s6787. Epub 2009 Nov 16.
2
Baseline platelet size is increased in patients with acute coronary syndromes developing early stent thrombosis and predicts future residual platelet reactivity. A case-control study.基线血小板体积增大与急性冠脉综合征患者早期支架血栓形成有关，并预测未来残余血小板反应性。一项病例对照研究。
Thromb Res. 2010 May;125(5):406-12. doi: 10.1016/j.thromres.2009.09.003. Epub 2009 Sep 27.
3
Significance of mean platelet volume on prognosis of patients with and without aspirin resistance in settings of non-ST-segment elevated acute coronary syndromes.非ST段抬高型急性冠脉综合征患者中平均血小板体积对阿司匹林抵抗和非阿司匹林抵抗患者预后的意义
Blood Coagul Fibrinolysis. 2009 Dec;20(8):686-93. doi: 10.1097/MBC.0b013e32833161ac.
4
Aspirin resistance after CABG.冠状动脉旁路移植术后的阿司匹林抵抗
Thorac Cardiovasc Surg. 2009 Aug;57(5):281-5. doi: 10.1055/s-0029-1185564. Epub 2009 Jul 23.
5
Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.氯吡格雷抵抗对药物洗脱支架经皮冠状动脉介入术后血栓形成事件的影响。
Thromb Res. 2009 May;124(1):46-51. doi: 10.1016/j.thromres.2008.10.007. Epub 2008 Nov 28.
6
Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients.评估氯吡格雷对稳定型冠状动脉疾病患者血小板功能抑制作用的四项试验比较。
Eur Heart J. 2008 Dec;29(23):2877-85. doi: 10.1093/eurheartj/ehn419. Epub 2008 Sep 30.
7
Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients.在慢性冠状动脉疾病患者中，不依从是阿司匹林抵抗的主要原因。
J Transl Med. 2008 Aug 29;6:46. doi: 10.1186/1479-5876-6-46.
8
The role of aspirin in cardiovascular prevention: implications of aspirin resistance.阿司匹林在心血管疾病预防中的作用：阿司匹林抵抗的影响
J Am Coll Cardiol. 2008 May 13;51(19):1829-43. doi: 10.1016/j.jacc.2007.11.080.
9
Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.冠状动脉搭桥手术中的阿司匹林：一种古老抗血栓药物的新进展与替代方案
Eur J Cardiothorac Surg. 2008 Jul;34(1):93-108. doi: 10.1016/j.ejcts.2008.03.023. Epub 2008 Apr 29.
10
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.在TRITON-TIMI 38试验中，对接受经皮冠状动脉介入治疗和支架置入术的急性冠状动脉综合征患者进行强化口服抗血小板治疗以降低缺血事件（包括支架血栓形成）：一项随机试验的亚分析
Lancet. 2008 Apr 19;371(9621):1353-63. doi: 10.1016/S0140-6736(08)60422-5. Epub 2008 Apr 2.
Zotero 插件